Porton Biopharma Revenue and Competitors

Salisbury, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Porton Biopharma's estimated annual revenue is currently $38.4M per year.(i)
  • Porton Biopharma's estimated revenue per employee is $201,000

Employee Data

  • Porton Biopharma has 191 Employees.(i)
  • Porton Biopharma grew their employee count by -5% last year.

Porton Biopharma's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Quality ControlReveal Email/Phone
3
Head Quality AssuranceReveal Email/Phone
4
Head Transformation FinanceReveal Email/Phone
5
Finance DirectorReveal Email/Phone
6
GXP Auditor - Compliance OfficerReveal Email/Phone
7
Director, Process & Analytical DevelopmentReveal Email/Phone
8
Director Commercial Partnerships & StrategyReveal Email/Phone
9
Unit ManagerReveal Email/Phone
10
CSV ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Porton Biopharma?

Porton Biopharma Limited (PBL) is a UK based company experienced in developing, manufacturing and bringing to market biopharmaceutical therapeutics and vaccines. PBL was corporatised out of Public Health England on 1st April 2015 to enable us to be better placed to grow our business, which is built upon decades of biopharmaceutical experience including the successful commercialisation and licensure of many therapies which now save thousands of lives every year, and generate revenues from world-wide sales. Our strategy as a new company with a distinguished heritage is to grow our existing business and product pipeline, whilst also building relationships across the industry. We offer expertise in developmental production of biologicals, including product characterisation, process and analytical validation and scalability for market. This allied with our experience of regulatory compliance gained from the licensure of products in different markets places us in an ideal position to offer this expertise to partners and bridge the gap to successfully bring products to market. As a growing company we are always looking to recruit talented individuals at all levels who have the drive and enthusiasm to help us get to where we want to be, and who are proud to be part of a team producing life-saving products that really make a difference. Visit our website to find out more and see our latest vacancies.

keywords:N/A

N/A

Total Funding

191

Number of Employees

$38.4M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Porton Biopharma News

2022-04-20 - Contract Bio-manufacturing Organization(CMO) Market Size ...

Abzena, Althea, Asymchem Laboratories Inc., Baxter Biopharma Solutions, Biomeva, ... KBI Biopharma, Lonza Group, MicroProtein Technologies, Patheon, Porton...

2022-04-20 - Anthrax Vaccines Market Size, Scope And Outlook | Zoetis Inc ...

Inc., Colorado Serum, PharmaAthene Inc., Vecol, Biogenesis Bago Inc., Porton Biopharma Inc., Merial, and Intervac. New Jersey, United States – The study is...

2022-04-17 - Anthrax Vaccines Market Size, Scope And Forecast | Zoetis Inc ...

Zoetis Inc., Emergent Bio-Solutions, Merck & Co. Inc., Colorado Serum, PharmaAthene Inc., Vecol, Biogenesis Bago Inc., Porton Biopharma Inc.,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$68.1M1935%N/A
#2
$57.9M1953%N/A
#3
$63.5M1994%N/A
#4
$56.2M201N/AN/A
#5
$73.6M2045%N/A